Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
220.00    0.00 (0.00%)
Bid:
208.00
Ask:
226.00
Spread: 18.00 (8.654%)
Market Cap: £1.31b
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

5 Feb 2025 07:00

RNS Number : 9014V
Kosmos Energy Limited
05 February 2025
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

04 February 2025

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Christopher J. Ball

31 January 2025

354,638

99,525

0

Josh R. Marion

31 January 2025

51,640

52,800

0

Josh R. Marion

3 February 2025

0

0

16,144

Ronald W. Glass

31 January 2025

51,640

50,000

0

Ronald W. Glass

3 February 2025

0

0

16,182

Andrew G. Inglis

31 January 2025

691,976

270,600

0

Andrew G. Inglis

3 February 2025

0

0

102,701

Neal D. Shah

31 January 2025

389,237

148,500

0

Neal D. Shah

3 February 2025

0

0

56,987

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.comMedia Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Christopher J. Ball

b)

Position / status

SVP and Chief Commercial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

(1) 354,638 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2022 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.

(2) 99,525 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2026, 2027 and 2028, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

3.18

Volume

454,163

Total

1,444,238.34

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

3.18

Volume

454,163

Total

1,444,238.34

e)

Date of the transactions

31 January 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Josh R. Marion

b)

Position / status

SVP and General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

(1) 51,640 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2022 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.

(2) 52,800 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2026, 2027 and 2028, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

3.18

Volume

104,440

Total

332,119.20

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

3.18

Volume

104,440

Total

332,119.20

e)

Date of the transactions

31 January 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

16,144 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1203

Volume

16,144

Total

50,374.13

d)

Aggregated information 

Price

3.1203

Volume

16,144

Total

50,374.13

e)

Date of the transactions

3 February 2025

f)

Place of the transaction

NYSE

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Ronald W. Glass

b)

Position / status

Vice President and Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

(1) 51,640 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2022 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.

(2) 50,000 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2026, 2027 and 2028, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

3.18

Volume

101,640

Total

323,215.20

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

3.18

Volume

101,640

Total

323,215.20

e)

Date of the transactions

31 January 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

16,182 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1203

Volume

16,182

Total

50,492.70

d)

Aggregated information 

Price

3.1203

Volume

16,182

Total

50,492.70

e)

Date of the transactions

3 February 2025

f)

Place of the transaction

NYSE

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

(1) 691,976 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2022 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.

(2) 270,600 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2026, 2027 and 2028, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

3.18

Volume

962,576

Total

3,060,991.68

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

3.18

Volume

962,576

Total

3,060,991.68

e)

Date of the transactions

31 January 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

102,701 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1203

Volume

102,701

Total

320,457.93

d)

Aggregated information 

Price

3.1203

Volume

102,701

Total

320,457.93

e)

Date of the transactions

3 February 2025

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

(1) 389,237 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2022 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.

(2) 148,500 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2026, 2027 and 2028, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares Granted or Vested

c)

Currency

USD

Price

3.18

Volume

537,737

Total

1,710,003.66

Shares sold or withheld

Currency

USD

Price

0

Volume

0

Total

0

d)

Aggregated information 

Price

3.18

Volume

537,737

Total

1,710,003.66

e)

Date of the transactions

31 January 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

56,987 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1203

Volume

56,987

Total

177,816.54

d)

Aggregated information 

Price

3.1203

Volume

56,987

Total

177,816.54

e)

Date of the transactions

3 February 2025

f)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSEFMLEISEIE
Date   Source Headline
2nd Jun 20267:00 amRNSReport on Payments to Governments
1st Jun 202612:57 pmRNSDirector/PDMR Shareholding
29th May 20267:00 amRNSResults of Annual Stockholders Meeting
5th May 20267:00 amRNS1st Quarter Results
16th Apr 20267:00 amRNSNotice of AGM
15th Apr 20267:00 amRNSFirst Quarter Results Date
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:01 amRNSResult of Equity Issue
11th Mar 20267:00 amRNSIssue of Equity
2nd Mar 20267:00 amRNSFourth Quarter Results
25th Feb 20267:00 amRNSSale of Equatorial Guinea Production Assets
20th Feb 20267:00 amRNSGhana License Extensions and Trading Update
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSFourth Quarter 2025 Results Date
16th Jan 20263:05 pmRNSPricing of Nordic Bond Issue
12th Jan 20267:00 amRNSLaunch of Nordic Bond Issue and Tender Offer
5th Jan 20267:00 amRNSOperational and Financial Update
3rd Nov 20257:00 amRNS3rd Quarter Results
7th Oct 20257:00 amRNSThird Quarter Results Date
1st Oct 20257:00 amRNSUpdate on Financial Progress
25th Sep 20251:00 pmRNSSenior Secured Term Loan with Shell
26th Aug 20257:00 amRNSRetirement of PDMR
4th Aug 20257:00 amRNS2nd Quarter Results
8th Jul 20257:00 amRNSSecond Quarter Results Date
23rd Jun 202511:16 amRNSGTA FLNG Commercial Operations Date Reached
12th Jun 20257:00 amRNSReport on Payments to Govts
9th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSResults of Annual Stockholders Meeting
4th Jun 20257:00 amRNSGhana license extensions
6th May 20257:00 amRNS1st Quarter Results
28th Apr 20257:00 amRNSPublication of Proxy Statement
17th Apr 20257:31 amRNSFirst LNG Cargo at Greater Tortue Ahmeyim Project
7th Apr 20257:00 amRNSFirst Quarter Results Date
24th Feb 20257:00 amRNSFourth Quarter Results
10th Feb 20257:00 amRNSFirst LNG at GTA
7th Feb 20257:00 amRNSDirector/PDMR Shareholding
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSFourth Quarter Results Date
2nd Jan 20257:00 amRNSFirst Gas at Greater Tortue Ahmeyim LNG Project
19th Dec 20242:41 pmRNSForm 8.3 - Tullow Oil PLC
19th Dec 20247:00 amRNSForm 8.3 - Kosmos Energy Ltd
18th Dec 20243:20 pmRNSForm 8.3 - Kosmos Energy Ltd.
18th Dec 202412:59 pmRNSForm 8.3 - Kosmos Energy
18th Dec 202411:49 amRNS20241217_KOSMOS ENERGY LTD_8.3_UK_BAC
18th Dec 202411:37 amRNSForm 8.5 (EPT/NON-RI) KOSMOS ENERGY LTD
17th Dec 20245:45 pmBUSForm 8.3 - Kosmos Energy Ltd.
17th Dec 20244:00 pmBUSForm 8.3 - Kosmos Energy Ltd.
17th Dec 20243:20 pmRNSForm 8.3 - Kosmos Energy Ltd.
17th Dec 20243:00 pmRNSForm 8.3 - Tullow Oil PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.